Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly Shareholders Equity (Quarterly) : 33.88B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 33.88B |
| March 31, 2026 | 31.20B |
| December 31, 2025 | 26.54B |
| September 30, 2025 | 23.79B |
| June 30, 2025 | 18.27B |
| March 31, 2025 | 15.76B |
| December 31, 2024 | 14.19B |
| September 30, 2024 | 14.24B |
| June 30, 2024 | 13.56B |
| March 31, 2024 | 12.81B |
| December 31, 2023 | 10.77B |
| September 30, 2023 | 11.22B |
| June 30, 2023 | 11.06B |
| March 31, 2023 | 11.19B |
| December 31, 2022 | 10.65B |
| September 30, 2022 | 10.07B |
| June 30, 2022 | 8.545B |
| March 31, 2022 | 9.331B |
| December 31, 2021 | 8.979B |
| September 30, 2021 | 7.757B |
| June 30, 2021 | 6.444B |
| March 31, 2021 | 6.899B |
| December 31, 2020 | 5.642B |
| September 30, 2020 | 4.827B |
| June 30, 2020 | 4.093B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.079B |
| December 31, 2019 | 2.607B |
| September 30, 2019 | 3.382B |
| June 30, 2019 | 2.780B |
| March 31, 2019 | 2.480B |
| December 31, 2018 | 9.829B |
| September 30, 2018 | 13.08B |
| June 30, 2018 | 11.56B |
| March 31, 2018 | 14.53B |
| December 31, 2017 | 11.59B |
| September 30, 2017 | 14.89B |
| June 30, 2017 | 14.10B |
| March 31, 2017 | 14.03B |
| December 31, 2016 | 14.01B |
| September 30, 2016 | 15.59B |
| June 30, 2016 | 14.64B |
| March 31, 2016 | 15.01B |
| December 31, 2015 | 14.57B |
| September 30, 2015 | 15.22B |
| June 30, 2015 | 14.67B |
| March 31, 2015 | 14.92B |
| December 31, 2014 | 15.37B |
| September 30, 2014 | 17.67B |
| June 30, 2014 | 17.98B |
| March 31, 2014 | 18.34B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 84.97B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| Bristol Myers Squibb Co. | 22.32B |
| Atai Beckley, Inc. | 176.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 142.28B |
| Total Liabilities (Quarterly) | 108.40B |
| Debt to Equity Ratio | 1.621 |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -0.29% |